- Home
- NXGL vs NNVC Comparison
NXGL vs NNVC Comparison
Compare NXGL & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXGL
- NNVC
- Stock Information
- Founded
- NXGL 1997
- NNVC 2005
- Country
- NXGL United States
- NNVC United States
- Employees
- NXGL N/A
- NNVC N/A
- Industry
- NXGL Medical/Dental Instruments
- NNVC Biotechnology: Pharmaceutical Preparations
- Sector
- NXGL Health Care
- NNVC Health Care
- Exchange
- NXGL Nasdaq
- NNVC Nasdaq
- Market Cap
- NXGL 22.7M
- NNVC 21.2M
- IPO Year
- NXGL 2021
- NNVC N/A
- Fundamental
- Price
- NXGL $4.73
- NNVC $1.51
- Analyst Decision
- NXGL
- NNVC Strong Buy
- Analyst Count
- NXGL 0
- NNVC 1
- Target Price
- NXGL N/A
- NNVC $6.50
- AVG Volume (30 Days)
- NXGL 168.1K
- NNVC 240.7K
- Earning Date
- NXGL 11-13-2024
- NNVC 02-12-2025
- Dividend Yield
- NXGL N/A
- NNVC N/A
- EPS Growth
- NXGL N/A
- NNVC N/A
- EPS
- NXGL N/A
- NNVC N/A
- Revenue
- NXGL $6,729,000.00
- NNVC N/A
- Revenue This Year
- NXGL $120.47
- NNVC N/A
- Revenue Next Year
- NXGL $38.19
- NNVC N/A
- P/E Ratio
- NXGL N/A
- NNVC N/A
- Revenue Growth
- NXGL 90.57
- NNVC N/A
- 52 Week Low
- NXGL $1.84
- NNVC $1.00
- 52 Week High
- NXGL $5.10
- NNVC $3.59
- Technical
- Relative Strength Index (RSI)
- NXGL 66.45
- NNVC 56.79
- Support Level
- NXGL $4.11
- NNVC $1.42
- Resistance Level
- NXGL $5.10
- NNVC $1.57
- Average True Range (ATR)
- NXGL 0.40
- NNVC 0.08
- MACD
- NXGL 0.08
- NNVC 0.01
- Stochastic Oscillator
- NXGL 78.98
- NNVC 69.05
About NXGL NexGel Inc
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating, and cross-linking technologies.
About NNVC NanoViricides Inc.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.